1. Home
  2. HPH vs PASG Comparison

HPH vs PASG Comparison

Compare HPH & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HPH
  • PASG
  • Stock Information
  • Founded
  • HPH 2010
  • PASG 2017
  • Country
  • HPH China
  • PASG United States
  • Employees
  • HPH N/A
  • PASG N/A
  • Industry
  • HPH
  • PASG Biotechnology: Pharmaceutical Preparations
  • Sector
  • HPH
  • PASG Health Care
  • Exchange
  • HPH NYSE
  • PASG Nasdaq
  • Market Cap
  • HPH 31.8M
  • PASG 31.1M
  • IPO Year
  • HPH 2019
  • PASG 2020
  • Fundamental
  • Price
  • HPH $4.36
  • PASG $0.33
  • Analyst Decision
  • HPH
  • PASG Strong Buy
  • Analyst Count
  • HPH 0
  • PASG 3
  • Target Price
  • HPH N/A
  • PASG $7.67
  • AVG Volume (30 Days)
  • HPH 85.0K
  • PASG 193.6K
  • Earning Date
  • HPH 01-01-0001
  • PASG 05-20-2025
  • Dividend Yield
  • HPH N/A
  • PASG N/A
  • EPS Growth
  • HPH N/A
  • PASG N/A
  • EPS
  • HPH N/A
  • PASG N/A
  • Revenue
  • HPH $286,996,105.00
  • PASG N/A
  • Revenue This Year
  • HPH N/A
  • PASG N/A
  • Revenue Next Year
  • HPH N/A
  • PASG N/A
  • P/E Ratio
  • HPH N/A
  • PASG N/A
  • Revenue Growth
  • HPH 1722.41
  • PASG N/A
  • 52 Week Low
  • HPH $3.76
  • PASG $0.30
  • 52 Week High
  • HPH $558.00
  • PASG $1.64
  • Technical
  • Relative Strength Index (RSI)
  • HPH 39.81
  • PASG 43.93
  • Support Level
  • HPH $5.02
  • PASG $0.33
  • Resistance Level
  • HPH $14.00
  • PASG $0.42
  • Average True Range (ATR)
  • HPH 1.92
  • PASG 0.04
  • MACD
  • HPH -0.28
  • PASG 0.00
  • Stochastic Oscillator
  • HPH 0.21
  • PASG 17.88

About HPH HIGHEST PERFORMANCE HLDGS INC

Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. The Group operate theree segments: (1) the insurance agency segment, which mainly consists of providing agency services for a wide range of life and non-life insurance products to individual clients, (2) the claims adjusting segment, which consists of providing pre-underwriting survey services, claim adjusting services, disposal of residual value services, loading and unloading supervision services, and consulting services, and (3) the wealth management segment, which mainly consists of providing distribution and managing wealth management services. Maximum revenue is from The Insurance Agency Segment.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: